Effectiveness of a Digital Strategy-based Educational Skills Group for Secondary Students With Organization and Academic Motivation Challenges (STAND-G)

May 17, 2022 updated by: Margaret Sibley, Seattle Children's Hospital

The purpose of this study is to test the effectiveness of a telehealth-delivered skills training versus active control group for middle and high school students with ADHD symptoms. Both programs will be delivered digitally (via Zoom).

Investigators will measure student functioning at baseline, post-group, and three-month follow-up. The primary outcomes are ADHD symptoms, student grade point average, and attendance as reported in the gradebook. Secondary outcomes include parent academic support, autonomy, academic motivation, and organization skills. Participant satisfaction with the group will be measured post-group. Group attendance and homework completion will also be measured.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

120 middle and high school students with elevated ADHD symptoms will be recruited for this study, which will take place over the course of the 2021-2022 academic year. The recruitment strategy will be to distribute information about the study opportunity to educator email lists in South Florida (see appended email template). Educators will be instructed to share information about the study to the parents of students who perceive to experience ADHD symptoms in their schools, regardless of special education status or documentation of a disability.

Students who enroll will be randomly assigned to either receive the STAND-G strategy-based group or a peer-support-based, active control group. Investigators will blind participants and their parents to which group is the active treatment by informing parents and students that participant will be randomly assigned to one of two groups to help improve school difficulties in youth. The two groups will be of equal duration, both will be led by the same instructors; and will differ only in content (teaching strategies vs. facilitating peer support and problem-solving conversations).

Students (and their parents) will complete assessments at baseline, post-group, and three months post-group. School records will be obtained for all time points.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Students will be required to,

  • be in the sixth through twelfth grade,
  • have elevated ADHD symptoms
  • documented impairment according to the SNAP
  • documented impairment according to Impairment Rating Scale.
  • Students must be 17.5 or younger at the time of enrollment to ensure that they are still under 18 at the expected completion of the study.

Parents of eligible students will also participate.

Exclusion Criteria:

Students may not be,

  • in a self-contained special education classroom,
  • possess intellectual disability
  • be non-English speaking
  • be older than 18 years old at time of enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral Parent Training/Organization Skills Training
Parents will receive 8 weeks of a 90 minute behavioral parent training protocol that focuses on supporting academic and behavioral success in adolescents with ADHD. Teens will receive a simultaneous 8 weeks of a 90 minute organization skills training group. Both groups will be delivered via telehealth.
See Arm description.
Other Names:
  • STAND-Group
Sham Comparator: Peer support
Parents and teens will each participate in 8 weeks of a 90 minute peer support group focused on exchange of shared experience and group problem-solving difficulties. Both groups will be delivered via telehealth.
See Arm description

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ADHD Symptoms
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Parent and Self Ratings on the SNAP Rating Scale
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Academic Impairment: Grade Point Average
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Official School Records
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Academic Impairment: School Attendance
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Official School Records
Change from Baseline through 3 months after Post-Treatment, an average of 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Academic Motivation
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Expectancy-Value Questionnaire -Self Version
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Academic Motivation
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Change Ruler -Self Version
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Executive Functions
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
BRIEF Rating Scale -Parent Version
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Organization, Time Management, and Planning
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Adolescent Academic Problems Checklist-Parent and Self Version will be used to measure organization, time management and planning
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Parent Academic Involvement
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Parent Academic Management Scale - Parent Version
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Academic Impairment Rating Scale
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Impairment Rating Scale - Parent Version
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Parent-Teen Conflict
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Conflict Behavior Questionnaire-20 - Parent, Self Version
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Goal Setting
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Goal Setting Questionnaire- Parent and Self
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Parent Autonomy Support
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Parent Promotion of Volitional Functioning- Self Report
Change from Baseline through 3 months after Post-Treatment, an average of 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment Satisfaction
Time Frame: At Post-treatment, approximately 8 weeks after initial group session
Parent and Self Report Satisfaction Survey
At Post-treatment, approximately 8 weeks after initial group session
Treatment Fidelity
Time Frame: Through Treatment Completion, an average of 8 weeks
Blinded Observers will observe to code for fidelity
Through Treatment Completion, an average of 8 weeks
Treatment Barriers
Time Frame: At Post-treatment, approximately 8 weeks after initial group session
Parent an Self Reported Barriers Survey
At Post-treatment, approximately 8 weeks after initial group session
Treatment Credibility
Time Frame: At Post-treatment, approximately 8 weeks after initial group session
Client Credibility Questionnaire-Parent and Self
At Post-treatment, approximately 8 weeks after initial group session
Video Conferencing Feasibility
Time Frame: At Post-treatment, approximately 8 weeks after initial group session
Video-Conferencing Questionnaire-Parent and Self
At Post-treatment, approximately 8 weeks after initial group session
Treatment Attendance
Time Frame: Through study completion, an average of 8 weeks, at each Session of Treatment
Group records
Through study completion, an average of 8 weeks, at each Session of Treatment
Treatment Homework Completion
Time Frame: Through study completion, an average of 8 weeks, at each Session of Treatment
Group records
Through study completion, an average of 8 weeks, at each Session of Treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 18, 2022

Primary Completion (Anticipated)

September 30, 2022

Study Completion (Anticipated)

September 30, 2022

Study Registration Dates

First Submitted

September 24, 2021

First Submitted That Met QC Criteria

May 17, 2022

First Posted (Actual)

May 23, 2022

Study Record Updates

Last Update Posted (Actual)

May 23, 2022

Last Update Submitted That Met QC Criteria

May 17, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 00003308

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We will submit data from this trial to the OSF data repository upon completion of the trial.

IPD Sharing Time Frame

Within six months of the completion of the trial

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ADHD

Clinical Trials on BPT/OST

3
Subscribe